The SureGene management team combines more than 50 years of diverse healthcare experience with a strong focus on diagnostics and pharmaceuticals. The team has a proven track record of building businesses and adding value to grow existing healthcare businesses. Experience ranges from startup ventures to Fortune 50 healthcare companies. Read about our management team.
SureGene’s scientific team comprises experts in the field of genomics, biostatistics, and clinical research with deep understanding of patient and market needs in the area of serious mental illness. Research focus includes programs to discover and validate clinically useful biomarkers that predict important safety factors, lack of effect, response to antipsychotic drugs, and development of diagnostic tests. Read about our scientific team.
In April 2009, a group of Chicago-based investment firms and individual investors partnered with SureGene’s scientific team to expand the organization and begin commercialization of SureGene’s genetic discoveries. SureGene is privately held. The investors have formed and financed several successful public and private healthcare companies. Read about our investors.